First-in-human study of PSMA-targeting agent, [18F]AlF-P16-093: dosimetry and initial evaluation in prostate cancer patients.

Purpose: This is a first-in-human study to evaluate the radiation dosimetry of a new prostate-specific membrane antigen (PSMA)-targeted radiopharmaceutical, [18F]AlF-P16-093, and also initial investigation of its ability to detect PSMA-positive tumors using PET scans in a cohort of prostate cancer (...

Descripción completa

Detalles Bibliográficos

Publicado en:	European Journal of Nuclear Medicine & Molecular Imaging Vol. 51; no. 6; pp. 1753 - 1763
Autores principales:	Zhao, Ruiyue, Ke, Miao, Lv, Jie, Liu, Shaoyu, Liu, Yuheng, Zhang, Jing, Xu, Lifu, Gu, Di, Li, Mingzhao, Cai, Chao, Liu, Yongda, Zeng, Guohua, Alexoff, David, Ploessl, Karl, Zhu, Lin, Kung, Hank F., Wang, Xinlu
Formato:	Journal Article
Publicado:	Springer Nature May2024
Acceso en línea:	Ver este registro en EBSCOhost